Company intelligence / Profile preview

International Bio Service

Phutthamonthon, Nakhon Pathom, Thailandibs.mahidol.ac.th ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

International Bio Service (IBS) is the largest and one of the most technologically advanced bioequivalence centers in Thailand. It has conducted hundreds of bioequivalence studies to support registration of generic pharmaceuticals globally. The center holds GLP accreditation from Thai authorities since 2010 and regular approval from Malaysia's NPRA since 2014. All operations comply with ICH-GCP guidelines, OECD GLP principles, and local/international regulations.

Modalities: Small molecule
Industry: Contract Research Organization

Beyond the preview

Go deeper on International Bio Service.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Bio Service.

Explore the full profile